SlideShare a Scribd company logo
Ocular manifestations of HIV
INTRODUCTION
( incidence & virology)
ETIOPATHOGENISIS
History
• 1st reported on June 5, 1981 when the U.S
Centers for Disease Control recorded a cluster
of Pneumocystis carinii pneumonia in five
homosexual men in Los Angeles
• Its cause HIV was identified in the early 1980s
2
• Human immunodeficiency virus (HIV) is a blood-
borne, sexually transmissible virus.
Global prevalence
• In 2014, WHO estimated 33.4 million people
worldwide living with HIV/AIDS,
• with 2.7 million new cases of HIV infection per
year
• and 2.0 million deaths due to AIDS
4
• According to UNAIDS report, 60 million people
have been infected since the start of
pandemic , with 25 million deaths, and 14
million orphaned children in southern Africa
alone
5
NACO 2015
Classification of HIV
• Two serological types
• HIV – 1 (world wide)
• HIV – 2 (West Africa & Portugal)
• HIV – 1 • HIV – 2
1.Type M 1. Type A, B,C,D and E
2. Type O
8
• HIV is a member of the genus Lentivirus, part of
the family Retroviridae .
• it is composed of two copies of positive single-
stranded RNA
• the single-stranded RNA is tightly bound to
nucleocapsid proteins, p7, and enzymes needed
for the development of the virion such as reverse
transcriptase, proteases, ribonuclease and integra
se.
• the viral envelope contains proteins from the
host cell and relatively few copies of the HIV
Envelope protein, which consists of a cap
made of three molecules known
as glycoprotein (gp) 120,
Type 1…
• HIV-1 probably originated from one or more
cross-species transfers from chimpanzees in
central Africa.
• HIV-2 is closely related to viruses that infect
sooty mangabeys in western Africa.
• Genetically, HIV-1 and HIV-2 are superficially
similar, but each contains unique genes and its
own distinct replication process.
Type 2…
• HIV-2 carries a slightly lower risk of transmission, and HIV-2
infection tends to progress more slowly to acquired immune
deficiency syndrome (AIDS).
• This may be due to a less-aggressive infection rather than a
specific property of the virus itself.
• Persons infected with HIV-2 tend to have a lower viral load
than people with HIV-1, and a greater viral load is associated
with more rapid progression to AIDS in HIV-1 infections
• HIV-2 is rare in the developed world. Consequently, most of
the research and vaccine and drug development has been
(perhaps unfairly) focused on HIV-1
etiopathogenesis
• Mode of infection
HIV Transmission
Requires:
1. Infected body fluid
AND
2. Entry into body
Mode of transmission
• Sexual contact – 70% of cases
• IV drug use – 27%
• Blood transfusion – 2-3%
• Perinatal transmission – 1%
16
3. Infected body fluids
Four Fluids, if infected, can transmit HIV
a. Blood
b. Semen
c. Vaginal Secretions
d. Breast Milk
If these enter the body
4. Which Fluids are safe?
Four Fluids that can’t transmit HIV
a. Spit/saliva
b. Pee/Urine
c. Sweat
d. Tears
How Does HIV get into a T Cell?
1. attaches to infection fighting T4 cell
2. Locks on to two entry areas of the T4 cell
at once. (Keys in lock)
3. Tricks T4 cell to allow Virus RNA to enter
What Does HIV do inside a T Cell?
1. Virus’s RNA changes into
DNA
2. Enters Cell nucleus &
becomes part of Host’s
DNA!
3. Programs T cell to produce
virus in abundance
4. New viruses bud off Host T
cell, killing T cell, & enters
bloodstream
5. New HIV viruses infect more
T cells
Flowchart
Binding to CD4 Internalization Uncoating
Reverse transcriptase
Integrated proviral DNA
Productive infection Latent infection
Mature HIV production
Cell lysis
21
New HIV viruses leaving a cell
Pathophysiology
• HIV attaches to T-cells & monocytes
/macrophage that display a membrane Ag-
complex known as CD4.
• The target cells of HIV show different cytopathic
effects
• CD4 + helper T-cells – decrease in number –
immunodef. – opportunistic infections
23
* Macrophage –
> decreased migration response to
chemoattractants
> defective intracellular killing of mircroorg.
(eg. Toxo. , Candida.)
> impaired Ag presentation
*excessive production of TNF-alpha –leads to
dementia , wasting , unexplained fever.
6. What is the “Window Period?”
The time period between a person’s exposure
& actual infection with HIV and until antibodies
are detectable in the body.
• After three months there are usually enough
antibodies to show on an AIDS test.
Nearly all people (99%) develop antibodies by
THREE months.
• Th pressence of any two major signs
associated with atleast one minor sign is
considered to be an indiaction of AIDS
Major signs include
• Loss of more than 10% of body weight
• Chronic fever
• Chronic diarrhoea of over 1 months duration
Minor signs include
• Chronic cough
• Itchy dermatitis
• Recurrent herpese zoster
• Oropharyngeal candidiasis
• Chronic progressive herpes simplex infection
• Generalised lymphadenopathy
• Eye involvement seen in 90% Autopsy cases
• Ocular complication in 75% of pts with AIDS
• Visual morbidity & blindness is the leading
cause of suicide in pt. with AIDS
• May be the first sign of HIV infection this shows
the Role of Eye consultant to make a sight
saving & life sustaining Diagnosis
29
To be continued…

More Related Content

What's hot

Corona virus infection
Corona virus infectionCorona virus infection
Corona virus infection
Gamal Agmy
 

What's hot (20)

Blood borne pathogens
Blood borne pathogensBlood borne pathogens
Blood borne pathogens
 
Laboratory diagnosis of HIV
Laboratory diagnosis of HIVLaboratory diagnosis of HIV
Laboratory diagnosis of HIV
 
Significant bacteriuria
Significant bacteriuriaSignificant bacteriuria
Significant bacteriuria
 
Human Herpes Virus.pptx
Human Herpes Virus.pptxHuman Herpes Virus.pptx
Human Herpes Virus.pptx
 
hepatitis B virus
hepatitis B virus hepatitis B virus
hepatitis B virus
 
Microbiology of HIV VIRUSES
Microbiology of HIV VIRUSESMicrobiology of HIV VIRUSES
Microbiology of HIV VIRUSES
 
Covid19 corona virus
Covid19 corona virusCovid19 corona virus
Covid19 corona virus
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Hospital acquired infections
Hospital acquired infectionsHospital acquired infections
Hospital acquired infections
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Hcv
HcvHcv
Hcv
 
Blood culture
Blood cultureBlood culture
Blood culture
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 
Influenza ppt(kannan) (1)
Influenza ppt(kannan)  (1)Influenza ppt(kannan)  (1)
Influenza ppt(kannan) (1)
 
Hepatitis b virus
Hepatitis b virusHepatitis b virus
Hepatitis b virus
 
Hepatitis B virus
Hepatitis B virusHepatitis B virus
Hepatitis B virus
 
Widal Test
Widal Test Widal Test
Widal Test
 
Hepatitis viruses
Hepatitis virusesHepatitis viruses
Hepatitis viruses
 
Herpes virus
Herpes virus Herpes virus
Herpes virus
 
Corona virus infection
Corona virus infectionCorona virus infection
Corona virus infection
 

Similar to introduction to HIV

Hiv aids seminar communti
Hiv aids seminar communtiHiv aids seminar communti
Hiv aids seminar communti
Bassam Daqaq
 
Communicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDSCommunicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDS
Ralph Bawalan
 
1. Basic facts of HIV ICAPRev.president ptx
1. Basic facts of HIV ICAPRev.president ptx1. Basic facts of HIV ICAPRev.president ptx
1. Basic facts of HIV ICAPRev.president ptx
yakemichael
 

Similar to introduction to HIV (20)

The ear anatomy and physiology
The ear anatomy and physiology The ear anatomy and physiology
The ear anatomy and physiology
 
HIV infection&AIDS 023.ppt
HIV infection&AIDS 023.pptHIV infection&AIDS 023.ppt
HIV infection&AIDS 023.ppt
 
(AIDS).ppt
(AIDS).ppt(AIDS).ppt
(AIDS).ppt
 
HIV pathology sufia husain 2017
HIV pathology sufia husain 2017HIV pathology sufia husain 2017
HIV pathology sufia husain 2017
 
PPT HIV SLY.pptx
PPT HIV SLY.pptxPPT HIV SLY.pptx
PPT HIV SLY.pptx
 
Hiv & pregnancy
Hiv & pregnancyHiv & pregnancy
Hiv & pregnancy
 
HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)
 
Aids
AidsAids
Aids
 
Hiv aids seminar communti
Hiv aids seminar communtiHiv aids seminar communti
Hiv aids seminar communti
 
Hiv infection-and-aids dr bikal
Hiv infection-and-aids dr bikalHiv infection-and-aids dr bikal
Hiv infection-and-aids dr bikal
 
Hiv
HivHiv
Hiv
 
Unit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptxUnit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptx
 
HIV - A Brief History
HIV - A Brief HistoryHIV - A Brief History
HIV - A Brief History
 
Hiv
HivHiv
Hiv
 
Communicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDSCommunicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDS
 
Hiv infection
Hiv infectionHiv infection
Hiv infection
 
HIV/AIDS Presentation
HIV/AIDS PresentationHIV/AIDS Presentation
HIV/AIDS Presentation
 
EPIDEMIOLOGY OF HIV.pptx
EPIDEMIOLOGY OF HIV.pptxEPIDEMIOLOGY OF HIV.pptx
EPIDEMIOLOGY OF HIV.pptx
 
1. Basic facts of HIV ICAPRev.president ptx
1. Basic facts of HIV ICAPRev.president ptx1. Basic facts of HIV ICAPRev.president ptx
1. Basic facts of HIV ICAPRev.president ptx
 
HIV & AIDS 05.12.2014
HIV & AIDS 05.12.2014HIV & AIDS 05.12.2014
HIV & AIDS 05.12.2014
 

Recently uploaded

Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
FatimaMary4
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 

Recently uploaded (20)

TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complex
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
The History of Diagnostic Medical imaging
The History of Diagnostic Medical imagingThe History of Diagnostic Medical imaging
The History of Diagnostic Medical imaging
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 

introduction to HIV

  • 1. Ocular manifestations of HIV INTRODUCTION ( incidence & virology) ETIOPATHOGENISIS
  • 2. History • 1st reported on June 5, 1981 when the U.S Centers for Disease Control recorded a cluster of Pneumocystis carinii pneumonia in five homosexual men in Los Angeles • Its cause HIV was identified in the early 1980s 2
  • 3. • Human immunodeficiency virus (HIV) is a blood- borne, sexually transmissible virus.
  • 4. Global prevalence • In 2014, WHO estimated 33.4 million people worldwide living with HIV/AIDS, • with 2.7 million new cases of HIV infection per year • and 2.0 million deaths due to AIDS 4
  • 5. • According to UNAIDS report, 60 million people have been infected since the start of pandemic , with 25 million deaths, and 14 million orphaned children in southern Africa alone 5
  • 6.
  • 8. Classification of HIV • Two serological types • HIV – 1 (world wide) • HIV – 2 (West Africa & Portugal) • HIV – 1 • HIV – 2 1.Type M 1. Type A, B,C,D and E 2. Type O 8
  • 9. • HIV is a member of the genus Lentivirus, part of the family Retroviridae . • it is composed of two copies of positive single- stranded RNA • the single-stranded RNA is tightly bound to nucleocapsid proteins, p7, and enzymes needed for the development of the virion such as reverse transcriptase, proteases, ribonuclease and integra se.
  • 10. • the viral envelope contains proteins from the host cell and relatively few copies of the HIV Envelope protein, which consists of a cap made of three molecules known as glycoprotein (gp) 120,
  • 11. Type 1… • HIV-1 probably originated from one or more cross-species transfers from chimpanzees in central Africa. • HIV-2 is closely related to viruses that infect sooty mangabeys in western Africa. • Genetically, HIV-1 and HIV-2 are superficially similar, but each contains unique genes and its own distinct replication process.
  • 12. Type 2… • HIV-2 carries a slightly lower risk of transmission, and HIV-2 infection tends to progress more slowly to acquired immune deficiency syndrome (AIDS). • This may be due to a less-aggressive infection rather than a specific property of the virus itself. • Persons infected with HIV-2 tend to have a lower viral load than people with HIV-1, and a greater viral load is associated with more rapid progression to AIDS in HIV-1 infections • HIV-2 is rare in the developed world. Consequently, most of the research and vaccine and drug development has been (perhaps unfairly) focused on HIV-1
  • 13.
  • 15. HIV Transmission Requires: 1. Infected body fluid AND 2. Entry into body
  • 16. Mode of transmission • Sexual contact – 70% of cases • IV drug use – 27% • Blood transfusion – 2-3% • Perinatal transmission – 1% 16
  • 17. 3. Infected body fluids Four Fluids, if infected, can transmit HIV a. Blood b. Semen c. Vaginal Secretions d. Breast Milk If these enter the body
  • 18. 4. Which Fluids are safe? Four Fluids that can’t transmit HIV a. Spit/saliva b. Pee/Urine c. Sweat d. Tears
  • 19. How Does HIV get into a T Cell? 1. attaches to infection fighting T4 cell 2. Locks on to two entry areas of the T4 cell at once. (Keys in lock) 3. Tricks T4 cell to allow Virus RNA to enter
  • 20. What Does HIV do inside a T Cell? 1. Virus’s RNA changes into DNA 2. Enters Cell nucleus & becomes part of Host’s DNA! 3. Programs T cell to produce virus in abundance 4. New viruses bud off Host T cell, killing T cell, & enters bloodstream 5. New HIV viruses infect more T cells
  • 21. Flowchart Binding to CD4 Internalization Uncoating Reverse transcriptase Integrated proviral DNA Productive infection Latent infection Mature HIV production Cell lysis 21
  • 22. New HIV viruses leaving a cell
  • 23. Pathophysiology • HIV attaches to T-cells & monocytes /macrophage that display a membrane Ag- complex known as CD4. • The target cells of HIV show different cytopathic effects • CD4 + helper T-cells – decrease in number – immunodef. – opportunistic infections 23
  • 24. * Macrophage – > decreased migration response to chemoattractants > defective intracellular killing of mircroorg. (eg. Toxo. , Candida.) > impaired Ag presentation *excessive production of TNF-alpha –leads to dementia , wasting , unexplained fever.
  • 25. 6. What is the “Window Period?” The time period between a person’s exposure & actual infection with HIV and until antibodies are detectable in the body. • After three months there are usually enough antibodies to show on an AIDS test. Nearly all people (99%) develop antibodies by THREE months.
  • 26. • Th pressence of any two major signs associated with atleast one minor sign is considered to be an indiaction of AIDS
  • 27. Major signs include • Loss of more than 10% of body weight • Chronic fever • Chronic diarrhoea of over 1 months duration
  • 28. Minor signs include • Chronic cough • Itchy dermatitis • Recurrent herpese zoster • Oropharyngeal candidiasis • Chronic progressive herpes simplex infection • Generalised lymphadenopathy
  • 29. • Eye involvement seen in 90% Autopsy cases • Ocular complication in 75% of pts with AIDS • Visual morbidity & blindness is the leading cause of suicide in pt. with AIDS • May be the first sign of HIV infection this shows the Role of Eye consultant to make a sight saving & life sustaining Diagnosis 29